IN SB0631 | 2019 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 5-0)
Status: Passed on April 29 2019 - 100% progression
Action: 2019-04-29 - Public Law 119
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Partisan Bill (Republican 5-0)
Status: Passed on April 29 2019 - 100% progression
Action: 2019-04-29 - Public Law 119
Text: Latest bill text (Enrolled) [PDF]
Summary
Drug classifications and drug schedules. Adds numerous substances to the definition of "synthetic drug". Adds epidiolex and brivaracetam to schedule V. Specifies that dronabinol is a schedule II controlled substance only in oral solution. Defines "fentanyl related substance" and adds it to schedule I. Moves certain fentanyl related substances from the definition of "synthetic drugs" in schedule II to schedule I. Adds Thiafentanil to schedule II. Makes conforming changes.
Title
Drug classifications and drug schedules. Adds numerous substances to the definition of "synthetic drug". Adds epidiolex and brivaracetam to schedule V. Specifies that dronabinol is a schedule II controlled substance only in oral solution. Defines "fentanyl related substance" and adds it to schedule I. Moves certain fentanyl related substances from the definition of "synthetic drugs" in schedule II to schedule I. Adds Thiafentanil to schedule II. Makes conforming changes.
Sponsors
Sen. Michael Young [R] | Sen. Aaron Freeman [R] | Sen. Mike Bohacek [R] | Rep. Wendy McNamara [R] |
Rep. Chuck Goodrich [R] |
Roll Calls
2019-04-16 - Senate - Senate - Senate concurred in House amendments (Y: 45 N: 2 NV: 2 Abs: 1) [PASS]
2019-04-08 - House - House - Third reading (Y: 95 N: 0 NV: 1 Abs: 4) [PASS]
2019-04-04 - House - House Floor - (Y: 64 N: 29 NV: 2 Abs: 5) [PASS]
2019-03-27 - House - House - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 1) [PASS]
2019-02-12 - Senate - Third reading (Y: 47 N: 1 NV: 1 Abs: 1) [PASS]
2019-02-05 - Senate - Senate - Committee Vote (Y: 8 N: 1 NV: 0 Abs: 0) [PASS]
2019-04-08 - House - House - Third reading (Y: 95 N: 0 NV: 1 Abs: 4) [PASS]
2019-04-04 - House - House Floor - (Y: 64 N: 29 NV: 2 Abs: 5) [PASS]
2019-03-27 - House - House - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 1) [PASS]
2019-02-12 - Senate - Third reading (Y: 47 N: 1 NV: 1 Abs: 1) [PASS]
2019-02-05 - Senate - Senate - Committee Vote (Y: 8 N: 1 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2019-04-29 | Senate | Public Law 119 |
2019-04-29 | Senate | Signed by the Governor |
2019-04-29 | Senate | Signed by the President of the Senate |
2019-04-24 | House | Signed by the Speaker |
2019-04-18 | Senate | Signed by the President Pro Tempore |
2019-04-16 | Senate | Senate concurred in House amendments; Roll Call 514: yeas 45, nays 2 |
2019-04-11 | Senate | Motion to concur filed |
2019-04-09 | House | Returned to the Senate with amendments |
2019-04-08 | House | Representative Goodrich added as cosponsor |
2019-04-08 | House | Third reading: passed; Roll Call 425: yeas 95, nays 0 |
2019-04-04 | House | Amendment #1 (Errington) ruled out of order |
2019-04-04 | House | Amendment #2 (Errington) ruled out of order |
2019-04-04 | House | Second reading: ordered engrossed |
2019-04-01 | House | Second reading: call withdrawn |
2019-03-28 | House | Committee report: amend do pass, adopted |
2019-03-07 | House | First reading: referred to Committee on Courts and Criminal Code |
2019-02-14 | Senate | Referred to the House |
2019-02-12 | Senate | Senator Freeman added as second author |
2019-02-12 | Senate | House sponsor: Representative McNamara |
2019-02-12 | Senate | Third reading: passed; Roll Call 117: yeas 47, nays 1 |
2019-02-11 | Senate | Second reading: ordered engrossed |
2019-02-07 | Senate | Committee report: amend do pass, adopted |
2019-02-05 | Senate | Senator Bohacek added as coauthor |
2019-01-16 | Senate | Committee report: amend do pass adopted; reassigned to Committee on Corrections and Criminal Law |
2019-01-15 | Senate | First reading: referred to Committee on Rules and Legislative Procedure |
2019-01-15 | Senate | Authored by Senator Young M |